Skip to main content

Effect of Onconase ± Tamoxifen on ASPC-1 Human Pancreatic Tumors in Nude Mice

  • Chapter
Book cover Oxygen Transport to Tissue XXIV

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 530))

Abstract

To evaluate changes in tumor physiological parameters after treatment with ONCONASE (ONC), we used laser Doppler flowmetery for tumor blood flow (TBF) in legs of nude mice bearing AsPC-1 human pancreatic carcinoma. Tumor interstitial fluid pressure (TIFP) was measured using the wick-inneedle technique, while intratumoral pO2 utilized O2 sensitive needle electrodes. TBF was significantly increased by an i.p. injection of ONC, then returned to the untreated levels at 150 min post-treatment. Single and multiple intraperitoneal injections of ONC significantly reduced TIFP (post-treatment at 1–7 days). ONC significantly improved tumor oxygenation evidenced by an increase in median pO2 from 4.2 mm Hg to 8.2 mm Hg. Since ONC had a synergistic interaction with tamoxifen (TAMX) on the cytotoxic clonogenicity of AsPC-1 tumor cells in vitro,we evaluated the antitumoral effects in vivo by ONC ± TAMX, using nude mice bearing AsPC-1 pancreatic tumor cells of ascite (intraperitoneally implanted) or solid (subcutaneously implanted to legs) tumors. ONC alone effectively retarded the tumor growth, but TAMX alone did not. ONC + TAMX was synergistically effective in inhibiting tumor growth.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Abbreviations

(ONC):

ONCONASE®

(TAMX):

tamoxifen

(TBF):

tumor blood flow

(TIFD):

tumor interstitial fluid pressure

References

  1. Jain RK. Barriers to drug delivery in solid tumors. Scientific Amer 1994;271:58–65.

    Article  CAS  Google Scholar 

  2. Lee I, Boucher Y, Jain RK. Nicotinamide can lower tumor interstitial hypertension: mechanistic and therapeutic implications. Cancer Res 1992;52:3237–3240.

    PubMed  CAS  Google Scholar 

  3. Lee I, Demhartner TJ, Boucher Y, Jain RK, Intaglietta M. Effects of hemodilution and resuscitation on tumor interstitial fluid pressure, blood flow, and oxygenation. Microvasc Res 1994;48:1–12.

    Article  PubMed  CAS  Google Scholar 

  4. Wu YN, Mikulski SM, Ardelt W, Rybak SM, Ypole RJ. A cytotoxic ribonuclease, study of the mechanism of onconase cytotoxicity. J Biol Chem 1993;268:10686–10693.

    PubMed  CAS  Google Scholar 

  5. Lin JJ, Newton DL, Mikulski SM, Kung HF, Youle RJ, Rybak SM. Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonuclease. Biochem Biophysical Res Comm 1994;204:156–162.

    Article  CAS  Google Scholar 

  6. Mikulski SM, Viera A, Ardelt W, Menduke H, Shogen K. Tamoxifen and trifluoroperazine (Stelazine) potentiate cytostatic/ cytotoxic effects of P-30 protein, a novel protein possessing anti-tumor activity. Cell Tissue Kinet 1990;23:237–246.

    PubMed  CAS  Google Scholar 

  7. Mikulski SM, Viera A, Shogen K. In vitro synergism between a novel amphibian oocytic ribonuclease (Onconase®) and tamoxifen, lovastatin and cisplatin, in human OVAR-3 ovarian carcinoma cell line. Int J Oncol 1992;1:779–785.

    PubMed  CAS  Google Scholar 

  8. Leunig M, Goetz AE, Dellian M, Zetterer G, Gamarra F, Jain RK, Messmer K. Interstitial fluid pressure in solid tumors following hyperthermia: possible correlation with therapeutic response. Cancer Res 1992;52:487–490.

    PubMed  CAS  Google Scholar 

  9. Vasandani VM, Wu Y, Mikulski SM, Youle RJ, Sung C. Molecular determinants in the plasma clearance and tissue distribution of ribonucleases of the ribonuclease A superfamily. Cancer Res 1996;56:4180–4186.

    PubMed  CAS  Google Scholar 

  10. McClay EM, Winski PJ, Jones JA, Jennertte II J, Gattoni-Celli S. ∆12-prostaglandin-J2, is cytotoxic in human malignancies and synergizes with both cisplatin and radiation. Cancer Res 1996;56:3866–3869.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lee, I., Lee, Y.H., Mikulski, S.M., Shogen, K. (2003). Effect of Onconase ± Tamoxifen on ASPC-1 Human Pancreatic Tumors in Nude Mice. In: Dunn, J.F., Swartz, H.M. (eds) Oxygen Transport to Tissue XXIV. Advances in Experimental Medicine and Biology, vol 530. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0075-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0075-9_18

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4912-9

  • Online ISBN: 978-1-4615-0075-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics